Dr Reddys Laboratories (RDY) EBITDA Margin (2009 - 2026)
Dr Reddys Laboratories' EBITDA Margin was 20.70% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 4.92 percentage points from 25.63% a year earlier but up 9.36 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Dr Reddys Laboratories' EBITDA Margin was 14.85% through Sep 30, 2026, down 11.04 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 22.52%, down 4.82 percentage points from FY2025.
- EBITDA Margin shows a five-year change of +2.97 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBITDA Margin was 27.34% in FY2025 (-2.24 pp), 29.58% in FY2024 (+1.21 pp), 28.38% in FY2023 (+9.09 pp) and 19.29% in FY2022 (-0.26 pp).
- Quarterly EBITDA Margin has moved between 6.00% (fiscal Q4 2026) and 31.48% (fiscal Q2 2024) over five years.
- Compared with a year earlier, EBITDA Margin has declined for 11 straight quarters, with an average year-over-year change of -6.59 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q4 2023 (a gain of 22.69 percentage points); the worst was fiscal Q4 2026 (a drop of 17.86 percentage points).
- Per Business Quant data, RDY's EBITDA Margin in the three fiscal quarters before Q2 2027 was 11.35% (Q1 2027), 6.00% (Q4 2026) and 19.92% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 42.49% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 20.70% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.70% |
| Jun 30, 2026 | 11.35% |
| Mar 31, 2026 | 6.00% |
| Dec 31, 2025 | 19.92% |
| Sep 30, 2025 | 25.63% |
| Jun 30, 2025 | 26.03% |
| Mar 31, 2025 | 23.86% |
| Dec 31, 2024 | 28.04% |
| Sep 30, 2024 | 26.85% |
| Jun 30, 2024 | 28.33% |
| Mar 31, 2024 | 26.36% |
| Dec 31, 2023 | 29.16% |
| Sep 30, 2023 | 31.48% |
| Jun 30, 2023 | 31.21% |
| Mar 31, 2023 | 30.92% |
| Dec 31, 2022 | 24.88% |
| Sep 30, 2022 | 29.03% |
| Jun 30, 2022 | 30.78% |
| Mar 31, 2022 | 8.23% |
| Dec 31, 2021 | 16.00% |
Dr Reddys Laboratories EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();